Optimind Pharma Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.012863 million compared to USD 0.053972 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | 0.00% |
Jul. 03 | Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding | CI |
Jun. 29 | Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 29, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 428K | |
+19.44% | 125B | |
+20.01% | 114B | |
+23.09% | 26.73B | |
-23.72% | 19.43B | |
-17.63% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |
- Stock Market
- Equities
- OMND Stock
- News Optimind Pharma Corp.
- Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022